Semuloparin

DB06294InvestigationalSmall molecule

Investigated for use/treatment in thrombosis.

Mechanism: Pharmacologically active on Antithrombin-III
Curator reviewed
Primary indication: Investigated for use/treatment in thrombosis.Curator reviewed
Also known as: Octaparin · Octaparine
Code names: AVE-5026

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

714Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Semuloparin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.